APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Specialty Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Companion Animal Specialty Drugs Market Outlook and Growth Opportunities 2026

20 December 2025196 pages

Choose your research edition.

Industry ResearchCompanion Animal Specialty Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Specialty Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Companion Animal Specialty Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Specialty Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Specialty Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Companion Animal Specialty Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Companion Animal Specialty Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animal Specialty Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animal Specialty Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Companion Animal Specialty Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Companion Animal Specialty Drugs market include Zoetis, Bayer, The J.M Smucker Company, Merial, Mars, Henry Schein, Elanco, Beaphar and Aratana therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Companion Animal Specialty Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animal Specialty Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animal Specialty Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Companion Animal Specialty Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Companion Animal Specialty Drugs Segment by Company

Zoetis

Bayer

The J.M Smucker Company

Merial

Mars

Henry Schein

Elanco

Beaphar

Aratana therapeutics

Companion Animal Specialty Drugs Segment by Type

Antibiotics

Parasiticides

Feed Additives

Vaccines

Other

Companion Animal Specialty Drugs Segment by Application

Pharmacy Stores

Veterinary Hospitals

Pet Care Clinics

Companion Animal Specialty Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Companion Animal Specialty Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Companion Animal Specialty Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Companion Animal Specialty Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Companion Animal Specialty Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Specialty Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Specialty Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Specialty Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Companion Animal Specialty Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animal Specialty Drugs industry.

Chapter 3: Detailed analysis of Companion Animal Specialty Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Companion Animal Specialty Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Companion Animal Specialty Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Companion Animal Specialty Drugs Industry Trends Table 2. Companion Animal Specialty Drugs Industry Drivers Table 3. Companion Animal Specialty Drugs Industry Opportunities and Challenges Table 4. Companion Animal Specialty Drugs Industry Restraints Table 5. Global Companion Animal Specialty Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Companion Animal Specialty Drugs Revenue Share by Company (2021-2026) Table 7. Global Companion Animal Specialty Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Companion Animal Specialty Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Companion Animal Specialty Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Companion Animal Specialty Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Companion Animal Specialty Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Companion Animal Specialty Drugs Company, Product Type & Application Table 13. Global Companion Animal Specialty Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Companion Animal Specialty Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antibiotics Table 18. Significant Companies of Parasiticides Table 19. Significant Companies of Feed Additives Table 20. Significant Companies of Vaccines Table 21. Significant Companies of Other Table 22. Global Companion Animal Specialty Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Companion Animal Specialty Drugs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Companion Animal Specialty Drugs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Companion Animal Specialty Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Companion Animal Specialty Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Companion Animal Specialty Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Companion Animal Specialty Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Companion Animal Specialty Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Companion Animal Specialty Drugs Sales Value Share by Type (2021-2026) Table 31. Global Companion Animal Specialty Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Pharmacy Stores Table 33. Significant Companies of Veterinary Hospitals Table 34. Significant Companies of Pet Care Clinics Table 35. Global Companion Animal Specialty Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Companion Animal Specialty Drugs Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Companion Animal Specialty Drugs Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Companion Animal Specialty Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Companion Animal Specialty Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Companion Animal Specialty Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Companion Animal Specialty Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Companion Animal Specialty Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Companion Animal Specialty Drugs Sales Value Share by Application (2021-2026) Table 44. Global Companion Animal Specialty Drugs Sales Value Share by Application (2027-2032) Table 45. Global Companion Animal Specialty Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Companion Animal Specialty Drugs Sales by Region (2021-2026) & (K Units) Table 47. Global Companion Animal Specialty Drugs Sales Market Share by Region (2021-2026) Table 48. Global Companion Animal Specialty Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Companion Animal Specialty Drugs Sales Market Share by Region (2027-2032) Table 50. Global Companion Animal Specialty Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Companion Animal Specialty Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Companion Animal Specialty Drugs Sales Value Share by Region (2021-2026) Table 53. Global Companion Animal Specialty Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Companion Animal Specialty Drugs Sales Value Share by Region (2027-2032) Table 55. Global Companion Animal Specialty Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Companion Animal Specialty Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Companion Animal Specialty Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Companion Animal Specialty Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Companion Animal Specialty Drugs Sales by Country (2021-2026) & (K Units) Table 60. Global Companion Animal Specialty Drugs Sales Market Share by Country (2021-2026) Table 61. Global Companion Animal Specialty Drugs Sales by Country (2027-2032) & (K Units) Table 62. Global Companion Animal Specialty Drugs Sales Market Share by Country (2027-2032) Table 63. Global Companion Animal Specialty Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Companion Animal Specialty Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Companion Animal Specialty Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Companion Animal Specialty Drugs Sales Value Market Share by Country (2027-2032) Table 67. Zoetis Company Information Table 68. Zoetis Business Overview Table 69. Zoetis Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zoetis Companion Animal Specialty Drugs Product Portfolio Table 71. Zoetis Recent Development Table 72. Bayer Company Information Table 73. Bayer Business Overview Table 74. Bayer Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bayer Companion Animal Specialty Drugs Product Portfolio Table 76. Bayer Recent Development Table 77. The J.M Smucker Company Company Information Table 78. The J.M Smucker Company Business Overview Table 79. The J.M Smucker Company Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. The J.M Smucker Company Companion Animal Specialty Drugs Product Portfolio Table 81. The J.M Smucker Company Recent Development Table 82. Merial Company Information Table 83. Merial Business Overview Table 84. Merial Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merial Companion Animal Specialty Drugs Product Portfolio Table 86. Merial Recent Development Table 87. Mars Company Information Table 88. Mars Business Overview Table 89. Mars Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mars Companion Animal Specialty Drugs Product Portfolio Table 91. Mars Recent Development Table 92. Henry Schein Company Information Table 93. Henry Schein Business Overview Table 94. Henry Schein Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Henry Schein Companion Animal Specialty Drugs Product Portfolio Table 96. Henry Schein Recent Development Table 97. Elanco Company Information Table 98. Elanco Business Overview Table 99. Elanco Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Elanco Companion Animal Specialty Drugs Product Portfolio Table 101. Elanco Recent Development Table 102. Beaphar Company Information Table 103. Beaphar Business Overview Table 104. Beaphar Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Beaphar Companion Animal Specialty Drugs Product Portfolio Table 106. Beaphar Recent Development Table 107. Aratana therapeutics Company Information Table 108. Aratana therapeutics Business Overview Table 109. Aratana therapeutics Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Aratana therapeutics Companion Animal Specialty Drugs Product Portfolio Table 111. Aratana therapeutics Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Companion Animal Specialty Drugs Distributors List Table 115. Companion Animal Specialty Drugs Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Companion Animal Specialty Drugs Product Image Figure 2. Global Companion Animal Specialty Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Specialty Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Companion Animal Specialty Drugs Sales (2021-2032) & (K Units) Figure 5. Global Companion Animal Specialty Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Companion Animal Specialty Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antibiotics Image Figure 10. Parasiticides Image Figure 11. Feed Additives Image Figure 12. Vaccines Image Figure 13. Other Image Figure 14. Global Companion Animal Specialty Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Companion Animal Specialty Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Companion Animal Specialty Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Companion Animal Specialty Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Companion Animal Specialty Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Companion Animal Specialty Drugs Sales Value Share by Type (2021-2032) Figure 20. Pharmacy Stores Image Figure 21. Veterinary Hospitals Image Figure 22. Pet Care Clinics Image Figure 23. Global Companion Animal Specialty Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Companion Animal Specialty Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Companion Animal Specialty Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Companion Animal Specialty Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Companion Animal Specialty Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Companion Animal Specialty Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Companion Animal Specialty Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Companion Animal Specialty Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Companion Animal Specialty Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Companion Animal Specialty Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Companion Animal Specialty Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Companion Animal Specialty Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Companion Animal Specialty Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Companion Animal Specialty Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Companion Animal Specialty Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Companion Animal Specialty Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Companion Animal Specialty Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Companion Animal Specialty Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Companion Animal Specialty Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Companion Animal Specialty Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Companion Animal Specialty Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Companion Animal Specialty Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Parasiticides
  • Feed Additives
  • Vaccines
  • Other
Applications
  • Pharmacy Stores
  • Veterinary Hospitals
  • Pet Care Clinics
Companies covered
  • Zoetis
  • Bayer
  • The J.M Smucker Company
  • Merial
  • Mars
  • Henry Schein
  • Elanco
  • Beaphar
  • Aratana therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Companion Animal Specialty Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Companion Animal Specialty Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Companion Animal Specialty Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Companion Animal Specialty Drugs Market Dynamics
  1. 2.1 Companion Animal Specialty Drugs Industry Trends
  2. 2.2 Companion Animal Specialty Drugs Industry Drivers
  3. 2.3 Companion Animal Specialty Drugs Industry Opportunities and Challenges
  4. 2.4 Companion Animal Specialty Drugs Industry Restraints
3 Companion Animal Specialty Drugs Market by Company
  1. 3.1 Global Companion Animal Specialty Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Companion Animal Specialty Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Companion Animal Specialty Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Companion Animal Specialty Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Companion Animal Specialty Drugs Company Ranking (2024-2026)
  6. 3.6 Global Companion Animal Specialty Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Companion Animal Specialty Drugs Company Product Type and Application
  8. 3.8 Global Companion Animal Specialty Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Companion Animal Specialty Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Companion Animal Specialty Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Companion Animal Specialty Drugs Market by Type
  1. 4.1 Companion Animal Specialty Drugs Type Introduction
  2. 4.1.1 Antibiotics
  3. 4.1.2 Parasiticides
  4. 4.1.3 Feed Additives
  5. 4.1.4 Vaccines
  6. 4.1.5 Other
  7. 4.2 Global Companion Animal Specialty Drugs Sales Volume by Type
  8. 4.2.1 Global Companion Animal Specialty Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Companion Animal Specialty Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Companion Animal Specialty Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Companion Animal Specialty Drugs Sales Value by Type
  12. 4.3.1 Global Companion Animal Specialty Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Companion Animal Specialty Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Companion Animal Specialty Drugs Sales Value Share by Type (2021-2032)
5 Companion Animal Specialty Drugs Market by Application
  1. 5.1 Companion Animal Specialty Drugs Application Introduction
  2. 5.1.1 Pharmacy Stores
  3. 5.1.2 Veterinary Hospitals
  4. 5.1.3 Pet Care Clinics
  5. 5.2 Global Companion Animal Specialty Drugs Sales Volume by Application
  6. 5.2.1 Global Companion Animal Specialty Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Companion Animal Specialty Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Companion Animal Specialty Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Companion Animal Specialty Drugs Sales Value by Application
  10. 5.3.1 Global Companion Animal Specialty Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Companion Animal Specialty Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Companion Animal Specialty Drugs Sales Value Share by Application (2021-2032)
6 Companion Animal Specialty Drugs Regional Sales and Value Analysis
  1. 6.1 Global Companion Animal Specialty Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Companion Animal Specialty Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Companion Animal Specialty Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Companion Animal Specialty Drugs Sales by Region (2027-2032)
  5. 6.3 Global Companion Animal Specialty Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Companion Animal Specialty Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Companion Animal Specialty Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Companion Animal Specialty Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Companion Animal Specialty Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Companion Animal Specialty Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Companion Animal Specialty Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Companion Animal Specialty Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Companion Animal Specialty Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Companion Animal Specialty Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Companion Animal Specialty Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Companion Animal Specialty Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Companion Animal Specialty Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Companion Animal Specialty Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Companion Animal Specialty Drugs Sales Value Share by Country, 2025 VS 2032
7 Companion Animal Specialty Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Companion Animal Specialty Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Companion Animal Specialty Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Companion Animal Specialty Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Companion Animal Specialty Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Companion Animal Specialty Drugs Sales by Country (2027-2032)
  6. 7.4 Global Companion Animal Specialty Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Companion Animal Specialty Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Companion Animal Specialty Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Companion Animal Specialty Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Companion Animal Specialty Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Companion Animal Specialty Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Companion Animal Specialty Drugs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Companion Animal Specialty Drugs Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 The J.M Smucker Company
  14. 8.3.1 The J.M Smucker Company Company Information
  15. 8.3.2 The J.M Smucker Company Business Overview
  16. 8.3.3 The J.M Smucker Company Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 The J.M Smucker Company Companion Animal Specialty Drugs Product Portfolio
  18. 8.3.5 The J.M Smucker Company Recent Developments
  19. 8.4 Merial
  20. 8.4.1 Merial Company Information
  21. 8.4.2 Merial Business Overview
  22. 8.4.3 Merial Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merial Companion Animal Specialty Drugs Product Portfolio
  24. 8.4.5 Merial Recent Developments
  25. 8.5 Mars
  26. 8.5.1 Mars Company Information
  27. 8.5.2 Mars Business Overview
  28. 8.5.3 Mars Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mars Companion Animal Specialty Drugs Product Portfolio
  30. 8.5.5 Mars Recent Developments
  31. 8.6 Henry Schein
  32. 8.6.1 Henry Schein Company Information
  33. 8.6.2 Henry Schein Business Overview
  34. 8.6.3 Henry Schein Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Henry Schein Companion Animal Specialty Drugs Product Portfolio
  36. 8.6.5 Henry Schein Recent Developments
  37. 8.7 Elanco
  38. 8.7.1 Elanco Company Information
  39. 8.7.2 Elanco Business Overview
  40. 8.7.3 Elanco Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Elanco Companion Animal Specialty Drugs Product Portfolio
  42. 8.7.5 Elanco Recent Developments
  43. 8.8 Beaphar
  44. 8.8.1 Beaphar Company Information
  45. 8.8.2 Beaphar Business Overview
  46. 8.8.3 Beaphar Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beaphar Companion Animal Specialty Drugs Product Portfolio
  48. 8.8.5 Beaphar Recent Developments
  49. 8.9 Aratana therapeutics
  50. 8.9.1 Aratana therapeutics Company Information
  51. 8.9.2 Aratana therapeutics Business Overview
  52. 8.9.3 Aratana therapeutics Companion Animal Specialty Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Aratana therapeutics Companion Animal Specialty Drugs Product Portfolio
  54. 8.9.5 Aratana therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Companion Animal Specialty Drugs Value Chain Analysis
  2. 9.1.1 Companion Animal Specialty Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Companion Animal Specialty Drugs Sales Mode & Process
  6. 9.2 Companion Animal Specialty Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Companion Animal Specialty Drugs Distributors
  9. 9.2.3 Companion Animal Specialty Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst